These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 7906387

  • 1. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma.
    Cryns VL, Thor A, Xu HJ, Hu SX, Wierman ME, Vickery AL, Benedict WF, Arnold A.
    N Engl J Med; 1994 Mar 17; 330(11):757-61. PubMed ID: 7906387
    [Abstract] [Full Text] [Related]

  • 2. p53 abnormalities in human parathyroid carcinoma.
    Cryns VL, Rubio MP, Thor AD, Louis DN, Arnold A.
    J Clin Endocrinol Metab; 1994 Jun 17; 78(6):1320-4. PubMed ID: 8200932
    [Abstract] [Full Text] [Related]

  • 3. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.
    Ishikawa J, Xu HJ, Hu SX, Yandell DW, Maeda S, Kamidono S, Benedict WF, Takahashi R.
    Cancer Res; 1991 Oct 15; 51(20):5736-43. PubMed ID: 1913692
    [Abstract] [Full Text] [Related]

  • 4. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
    Xing EP, Yang GY, Wang LD, Shi ST, Yang CS.
    Clin Cancer Res; 1999 May 15; 5(5):1231-40. PubMed ID: 10353761
    [Abstract] [Full Text] [Related]

  • 5. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas.
    Tahara H, Smith AP, Gas RD, Cryns VL, Arnold A.
    Cancer Res; 1996 Feb 01; 56(3):599-605. PubMed ID: 8564978
    [Abstract] [Full Text] [Related]

  • 6. Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate.
    Tahara H, Smith AP, Gaz RD, Zariwala M, Xiong Y, Arnold A.
    J Bone Miner Res; 1997 Sep 01; 12(9):1330-4. PubMed ID: 9286748
    [Abstract] [Full Text] [Related]

  • 7. Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas.
    Hemmer S, Wasenius VM, Haglund C, Zhu Y, Knuutila S, Franssila K, Joensuu H.
    Am J Pathol; 2001 Apr 01; 158(4):1355-62. PubMed ID: 11290553
    [Abstract] [Full Text] [Related]

  • 8. Defining a molecular phenotype for benign and malignant parathyroid tumors.
    Fernandez-Ranvier GG, Khanafshar E, Tacha D, Wong M, Kebebew E, Duh QY, Clark OH.
    Cancer; 2009 Jan 15; 115(2):334-44. PubMed ID: 19107770
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis.
    Stojadinovic A, Hoos A, Nissan A, Dudas ME, Cordon-Cardo C, Shaha AR, Brennan MF, Singh B, Ghossein RA.
    Hum Pathol; 2003 Jan 15; 34(1):54-64. PubMed ID: 12605367
    [Abstract] [Full Text] [Related]

  • 15. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.
    Woodard GE, Lin L, Zhang JH, Agarwal SK, Marx SJ, Simonds WF.
    Oncogene; 2005 Feb 10; 24(7):1272-6. PubMed ID: 15580289
    [Abstract] [Full Text] [Related]

  • 16. Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma.
    Kim HK, Oh YL, Kim SH, Lee DY, Kang HC, Lee JI, Jang HW, Hur KY, Kim JH, Min YK, Chung JH, Kim SW.
    Head Neck; 2012 Feb 10; 34(2):201-6. PubMed ID: 21717519
    [Abstract] [Full Text] [Related]

  • 17. A possible tumor suppressor gene for parathyroid adenomas.
    Iwasaki H.
    Int Surg; 1996 Feb 10; 81(1):71-6. PubMed ID: 8803711
    [Abstract] [Full Text] [Related]

  • 18. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
    Huang L, Lang D, Geradts J, Obara T, Klein-Szanto AJ, Lynch HT, Ruggeri BA.
    Mol Carcinog; 1996 Feb 10; 15(2):85-95. PubMed ID: 8599583
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
    Tominaga Y, Tsuzuki T, Uchida K, Haba T, Otsuka S, Ichimori T, Yamada K, Numano M, Tanaka Y, Takagi H.
    Kidney Int; 1999 Apr 10; 55(4):1375-83. PubMed ID: 10201002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.